Hormone therapy for menopause shown safe and effective in new studies

Recent analyses of the Women’s Health Initiative (WHI) data indicate that hormone therapy, when started within ten years of menopause, reduces mortality risk and may offer cardiovascular benefits, countering earlier concerns about heart disease and cancer. The 2024 WHI follow‑up also confirms that hormone therapy remains the most effective treatment for severe hot flashes.

Experts stress that therapy should be individualized: localized vaginal estrogen is safe for genitourinary symptoms, while systemic regimens require careful assessment of cardiovascular and clotting risks, especially for women with a uterus who need combined estrogen‑progestogen. The FDA’s black‑box warning remains, but newer formulations and early‑initiation protocols appear to mitigate many of the previously reported dangers.